April seventeen, 2007 The exchange-traded account Biotech HOLDRS( AMEX: BBH) has solemnly been recuperating from the high improvement durability from early Jan to mid-March 2007. With core positions in Genentech( NYSE: DNA), Amgen( NASDAQ: AMGN) as well as Biogen( NASDAQ: BIIB), is it protected to buy Biotech HOLDRS nonetheless? Ina. ..
Tags: DNA, General DNALeave a Comment